# Novel plasmid vector.

## Abstract
Disclosed is a plasmid vector which is a chimera plas mid constructed with a chromosomal DNA fragment of a microorganism belonging to the genus Schizosacch aromyces and a plasmid of a microorganism belonging to the genus Escherichia and is autonomously replicable in both microorganisms belonging to the genera Schizosacch aromyces and Escherichia.

## Claims
WHsT IS CLAIMED I5 1. A plasmid vector which is a chimera plasmid con structed with a chromosomal DNA fragment of a microorganism belonging to the genus Schizosaccharomyces and a plasmid of a microorganism belonging to the genus Escherichia and is autonomously replicable in both microorganisms belonging to the genera Schizosaccharomyces and Escherichia. 2. The plasmid vector according to claim 1, wherein the microorganism belonging to the genuS Schizosaccharomyces is Schizosaccharomyces pombe. 3. The plasmid vector according to claim 1, wherein the chromosonal DNA fragment is a DNA complementing ural mutation of a microorganism of the genus Schizosaccharo myces or PvrB mutation of a microorganism of Escherichia coli. 4. The plasmid vector according to claim Ir wherein the plasmid of the microorganism belonging to the genusEscherichia is a plasmid of Escherichia coli. 5. The plasmid vector according to claim 4, wherein the plasmid is selected from pBR322, pBR325, pBR327, pBR328, pMB9, pCRl, Ras2124, pBR313, pACYC177 and pACYC184. 6. The plasmid vector according to claim 1, which is characterized in that the plasmid is pFYM201 or pFYM225. 7. A derivative of the plasmid vector, wherein a gene responsible for resistance to an antibiotic other than ampiciilin is incorporated in the plasmid vector of claim 1. 8. The derivative according to claim 7, wherein the gene responsible for resistance to an antibiotic is a gene coding for an enzyme inactivating gentamycin antibioticG 418. 9. Plasmid vector pFYM225G4.

## Description
TiTtZ OF TXv INVENTION NOVEL PLASMID VECTORBackground of the Invention The present invention relates to a novel plasmid vector. More specifically, the present invention relates to a plasmid vector which is a chimera plasmid constructed with a chromosomal DNA fragment of a microorganism belonging to the genus Schizosaccharomyces and a plasmid of a microorganism belonging to the genus Escherichia and is autonomously replicable in both microorganisms belonging to the genera Schizosaccharomyces and Escherichia. Host vector systems for yeast have been developed mainly with baker s yeast Saccharomyces cerevisiae as known with YRp7, YEp13, YIpl, pJDB219 or the like Akio Toh e et al. Protein, Nucleic Acid and Enzyme 26, 476, 1981 . The study of Beach et al D. Beach et al Nature 290, 140 142 1981 relates to the host vector system with Schizomycetes such as Schizosaccharomyces. Beach et al found that a shuttle vector pJDB248 containing the leucin 2 gene of Saccharomvces cerevisiae, 2 m plasmid and plasmid pMB9 of Escherichia coli J.D. Beggs et al. Nature 275 104 109 1978 and its derivatives are applicable to the effective transformation of Schizosaccharo mvces pombe. The present inventor has cloned Schizosaccharomyces pombe DNA fragment which is able to complement PyrB pyrimidine B mutation of Escherichia coli into pBR322.The clones were reported as pFYMl, pFYM2 and pFYM3 Yamamoto et al. Mol. Gen. Genet. 182, 426 429 1981 . The preSent inventor has studied and found that a derivative of pFYM201 is autonomously replicable in both Escherichiacoliand Schizosaccharomvces pombe and is applicable as plasmid vector in host vector system for the genus Schizosaccharomyces. Su3marz or the Invention The present invention provides a plasmid vector which is a chimera plasmid constructed with a chromosomalDNA fragment of a microorganism belonging to the genusSchizosaccharomyces and a plasmid of a microorganism belonging to the genus Escherichia and is autonomously replicable in both microorganisms belonging to the generaSchizosaccharomyces and Escherichia. As the microorganism belonging to the genusSchizosaccharomyces, those belonging to the species Schizosaccharomyces pombe are employed. As the chromosomal DNA fragment of a microorganism belonging to the genus Schizosaccharomyces, a DNA fragment which is able to complement ural mutation of Schizosaccharomyces pombe i.e. a DNA fragment containing the structural gene of aspartate transcarbamylase is employed. The DNA fragment of Schizosaccharomyces pombe can be prepared according to the method of Cryer et al Method in CellBiology 12, 39 1975 , Academic Press, New York, Prescott D.X. wed . As the plasmids of a microorganism belonging to the genus Escherichia, the plasmids derived from Escherichia coli such as pBR322, pBR325, pBR327, pBR328, pMB9, pCRl, RSF2124, pBR313, pACYC177 and pACVC184 are used, These plasmids are prepared by the methods described in P. Guerry et al., J. Bacteriol. 116, 1064 1973 . Brief Description of the Drawinas Fig. 1 shows the structures of plasmids pFYM2, pFYM201 and pFYM225. Fig. 2 shows the structure of plasmid pFYM225G4. In the drawings, the thick line represents theDNA derived from chromosome of Schizosaccharomyces pombe, the fine line represents the DNA derived from pBR322, and the boxed line represents the DNA derived from transposon Tn903 existing on plasmid pAJ 43, and coding for an enzyme inactivating G418. The abbreviations represent the following restriction enzymes, respectively. Ba BamRI, Bg BglII, C ClaI, E. EcoRI, H Hindlil, Ps PstI, Pv PvuZ, X. xhol. retailed Desc intion of the Invention Preparation of the chimera plasmid is carried out by conventional recombinant DNA technology. For example, a plasmid DNA is digested with restriction enzymes and the enzyme is inactivated by heating. A DNA fragment derived from the genus Schizosaccharomyces is ligated with the digested plasmid DNA according to the method of Williams et al., B.G. Williams et al., J. Biol.Chem. 252, 7344 7354 1977 10 Selection of the plasmid of the present invention is carried out using a selection marker retained in the plasmid DNA. i Transformation of microorganisms of the genusEscherichia such as Escherichia coli with the plasmid vector of the present invention is carried out according to the method of Cohen et al. S.N. Cohen Proc. Natl. Acas. Sci. U.S.A. 69, 2110 2114 1972 . Transformation of microorganisms of the genus Schizosaccharomyces such asSchizosaccharomyces pombe with the plasmid vector of the present invention is carried out according to the method of Beach et al. D. Beach et al., Nature 290, 140 142 1981 . The plasmid vector of the present invention is autonomously replicable in both Escherichia coli andSchizosaccharomyces pombe and is useful as a shuttle vector.Further, plural plasmid vectors of the present invention exist in a form of a polymer chain in a host microorganism.This is one of the characteristics which distinguish the present vector from known vectors of yeast. The simultaneous use of the plasmid vector of the present invention and other plasmids such as pFYM2 in transformation treatment can elevate the ratio of transformation frequency. Examples of the present invention are as follows.Example 1 Construction of plasmid pFYM201 In this example, 5 pg of plasmid pFYM2 Mol. Gen.Genet. 182, 426 429 1981 DNA was dissolved in 50 p1 of a mixture of 10 mM Tris HCl pH 7.5 , 7 mM MgC12, 50 mM NaCl and 6 mM 2 mercaptoethanol. 10 units of restriction enzyme PvuII product of Takara Shuzo Co. was added and the mixture was incubated at 370C for 2 hours. The reaction solution was heated at 65 C for 5 minutes to inactivate the enzyme and 5 yl of 3M sodium acetate and 125 1 of ethanol were added. The mixture was allowed to stand at 200C for 2 hours and subjected to centrifugation at 12,000 r.p.m. for 5 minutes to recover the DNA as precipitates.The whole DNA recovered was dissolved in 30 l of a mixture of 20 mM Tris ECl pH 7.5 , 10 mM MgCI21 10 mM dithiothreitol and 0.5 mM ATP and 4 units of T4DNA ligase product of New England Biolabs, the same as hereinbelow was added. The mixture was allowed to react at 40C overnight. Escherichia coli PyrB mutant NF305 PyrB43, leuB, hisG, lysA, argG, metB, recA, F Mol. Gen. Genet. 182, 426 429 1981 was transformed using the reaction solution according to a conventional method tS.N. Cohen Proc.Natl. Acad. Sci., 69,2110 2114 1972 and a transformant resistant to 40 pg ml ampicillin ApR was selected from the obtained transformants. The transformant was cultured in an aqueous medium in a conventional way to isolate 50 g of plasmid from the cultured medium. The plasmid thus obtained has the structure illustrated as plasmid pFYM201 in Fig. 1. The structure of pFYM2Ol was confirmed by agarose gel electrophoresis after digestion with Bindill, ClaI, PvuIZ and PstI alone or in combination.The size of plasmid pFYMZOl is about 6.1 kilobases Xb . Escherichia coli U 201 containing plasmid pFYM201 has been deposited with the Fermentation Research Institute, Agency of Indus trial Science and Technology under accession number FERM P 6768 FERM BP 348 .Example 2 Construction of plasmid pFYM225 In this example, 3 g of plasmid pFYM201 obtained in Example 1 was dissolved in 30 p1 of a mixture of 10 mM Tris Cl pH 7.5 , 7 mM MgCl2 and 6 mM 2 mercaptoethanol.6 units of restriction enzyme Clal product of. Takara Shuzo Co. was added and the mixture was incubated at 370C for 2 hours. The reaction solution was heated at 65C for 5 minutes to inactivate the enzyme and 3 iil of 3M sodium acetate and 75 l of ethanol were added. The mixture was allowed to stand at 200C for 2 hours and subjected to centrifugation at 12,000 r.p.m. for 5 minutes to recover the DNA as precipitates. The whole DNA recovered was dis solved in 30 1 of a solution containing 20 mM Tris HCl pH 7.5 , 10 mM MgCl2, 10 mM dithiothreitol and 0.5 mM ATP. 4 units of T4DNA ligase was added and the mixture was allowed to react at 40C overnight.Escherichia coli PyrB mutant NF305 was transformed using the reaction solu tion as in Example 1 and a transformant resistant to 40 ug ml ampicillin was obtained. The transformant was cultured in an aqueous medium in a conventional way and 30 pg of plasmid was isolated from the culture medium by the same method as in Example 1. The plasmid thus obtained has the structure illustrated as pladmid pFYM225 in Fig. 1. The structure of pFYM225 was confirmed by agarose gel electrophoresis after digestion with EcoRI, ClaI, BamRI, BglII, HindIII, PvuII and PstI alone or in combination. The size of plasmid pFYM225 is about 4.6 Kb. Escherichia coli U 225 containing plasmid pFYM225 has been deposited with the Fermentation Research Institute, Agency of Industrial Science and Technology under acces sion number FERM P 6769 FERM BP 349 . Example 3 Construction of plasmid pFYM225G4 In this example 2 pg of plasmid pFYM225 obtained in Example 2 was dissolved in 30 iil of a mixture bf 10 mM Tris HCl pH 7.5 , 7 mM MgC12, 50 mM NaCI and 6 mM 2mercaptoethanol. 4 units of restriction enzyme PvuII product of Takara Shuzo Co., the same as hereinbelow was added and the mixture was incubated at 370C for 2 hours. The reaction solution was heated at 650C for 5 minutes to inactivate the enzyme. Separately, 5 Vg of plasmid pA043 A. Oka et al. Nature 276, 845 847 1978 this plasmid includes a DNA sequence coding for an enzyme which inactivates the anti biotic gentamycin G 4183 was dissolved in 50 1 of a mixture of 10 mM Tris Cl pH 7.5 , 7 mM MgCl2, 50 mM NaCl and 6 mM 2 mercaptoethanol. 10 units of PvuII was added and the mixture was incubated at 370C for 3 hours. The reaction solution was heated at 650C for 5 minutes to inactivate the enzyme. Each reaction solution was treated with ethanol to obtain the DNA as precipitates in the same way as inExample 2. The whole of each DNA was dissolved in 30 l of a solution containing 20 mM Tris HCl pH 7.5 , 10 mMMgCl2 and 10 mM dithiothreitol. 15 pL each of the solutions were mixed and 0.5 mM final concentration ATP and 4 units final amount of T4DNA ligase were added. The mixture was allowed to react at 40C overnight. Escherichia coli PyrB mutant NF305 was transformed using the reaction mixture as in Example 1 and a transformant resistant to 40 ug ml ampicillin and 50 pg ml kanamycin was obtained. The transformant was cultured in an aqueous medium in a conventional way and 55 g of plasmid was isolated from the cultured medium as in Example 1. The plasmid has the structure illustrated as plasmid pFYZI225G4 in Fig. 2. The structure of plasmid pFYM225G4 was. confirmed by agarose gel electrophoresis after digestion with PstT, EcoRI, ClaI, BamBI, BglTI, HindIII, PvuII and XhoI alone or in combination. The size of plasmid pFYS225G4 is about 6.3 Rb. Escherichia coli U 225G4 containing plasmid pFYM225G4 has been deposited with the Fermentation ResearchInstitute, Agency of Industrial and Science Technology under accession number FERM P 6770 FERM BP 350 . Example 4 Schizosaccharomyces pombe JY171 h ural a derivative strain of ATCC 24969 C.R. Lab. Carlsberg Serve Physio. 24 381 480, 1950 l was transformed with plasmids pFYM201, pFYM225 and pFYM225G4 obtained inExamples 1, 2 and 3, respectively by the method of Beach D. Beach et al. Nature 290, 140 142 1981 1 and ura transformant was obtained. The frequencies of the transformations are described in Table 1. Table 1 Plasmid 1 g of DNA, ural transformants per 108 spheroplasts pFYM201 4.4 x 103 pFYM225 3.9 x 10 pFYM225G4 60 0 . Among 60 ura transformants of pFYM225G4, 20 strains were resistant to 100 wg ml G418 which is one of the gentamicins.Example 5 Schizosaccharomyces pombe JY171 FERM BP 335 was transformed with plasmid pFYM225G4 in the coexistence of plasmid pFYM2 Mol. Gen. Genet., 182, 426 429 1981 as inExample 4. The results are shown in Table 2. Table 2 1 pg of DNA, 1 ug of DNA, ura transformants ura and G418 re Plasmid per 108 spheroplasts sistant.transfor mantis per 108 spheroplasts pFYM225G4 60 20 pEYM225G4 1.0 x 104 8 x 10 pFYM2 0 0 Table 2 shows that the coexistence of pFYM2 and pFYM225G4 elevates significantly the frequency of transformation cotransformation .